Chinese General Practice ›› 2023, Vol. 26 ›› Issue (36): 4587-4594.DOI: 10.12114/j.issn.1007-9572.2023.0339
Special Issue: 肿瘤最新文章合辑
• Article • Previous Articles Next Articles
Received:
2023-04-09
Revised:
2023-07-12
Published:
2023-12-20
Online:
2023-07-21
Contact:
ZHOU Shangcheng
通讯作者:
周尚成
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0339
Figure 2 Changes in standardized mortality rate,DALYs rate,YLDs rate,and YLDs rate for esophageal cancer attributable to tobacco in China from 1990 to 2019
分类 | 时间(年) | APC(%) | 95%CI(%) | P值 | AAPC(%) | 95%CI(%) | P值 |
---|---|---|---|---|---|---|---|
总人群 | 1990—1998 | -0.1 | (-0.4,0.1) | 0.027 | -1.4 | (-1.6,-1.2) | <0.001 |
总人群 | 1998—2004 | 1.8 | (1.3,2.3) | <0.001 | |||
总人群 | 2004—2014 | -4.4 | (-4.6,-4.3) | <0.001 | |||
总人群 | 2014—2017 | -2.2 | (-3.7,-0.7) | 0.007 | |||
总人群 | 2017—2019 | 0.5 | (1.3,2.3) | 0.055 | |||
女性 | 1990—1993 | 3.7 | (2.6,4.8) | <0.001 | -3.3 | (-3.6,-2.9) | <0.001 |
女性 | 1993—1998 | -0.2 | (-0.9,0.5) | 0.052 | |||
女性 | 1998—2001 | 1.4 | (-0.8,3.8) | 0.019 | |||
女性 | 2001—2004 | -1.1 | (-3.4,1.3) | 0.034 | |||
女性 | 2004—2015 | -8.3 | (-8.5,-8.2) | <0.001 | |||
女性 | 2015—2019 | -2.7 | (-3.3,-2.1) | <0.001 | |||
男性 | 1990—1997 | -0.6 | (-0.9,-0.3) | <0.001 | -1.3 | (-1.4,-1.1) | <0.001 |
男性 | 1997—2004 | 1.7 | (1.3,2.1) | <0.001 | |||
男性 | 2004—2015 | -3.8 | (-3.9,-3.6) | <0.001 | |||
男性 | 2015—2019 | -0.6 | (-1.2,-0.1) | 0.026 |
Table 1 Trends in esophageal cancer mortality attributable to tobacco in China from 1990 to 2019
分类 | 时间(年) | APC(%) | 95%CI(%) | P值 | AAPC(%) | 95%CI(%) | P值 |
---|---|---|---|---|---|---|---|
总人群 | 1990—1998 | -0.1 | (-0.4,0.1) | 0.027 | -1.4 | (-1.6,-1.2) | <0.001 |
总人群 | 1998—2004 | 1.8 | (1.3,2.3) | <0.001 | |||
总人群 | 2004—2014 | -4.4 | (-4.6,-4.3) | <0.001 | |||
总人群 | 2014—2017 | -2.2 | (-3.7,-0.7) | 0.007 | |||
总人群 | 2017—2019 | 0.5 | (1.3,2.3) | 0.055 | |||
女性 | 1990—1993 | 3.7 | (2.6,4.8) | <0.001 | -3.3 | (-3.6,-2.9) | <0.001 |
女性 | 1993—1998 | -0.2 | (-0.9,0.5) | 0.052 | |||
女性 | 1998—2001 | 1.4 | (-0.8,3.8) | 0.019 | |||
女性 | 2001—2004 | -1.1 | (-3.4,1.3) | 0.034 | |||
女性 | 2004—2015 | -8.3 | (-8.5,-8.2) | <0.001 | |||
女性 | 2015—2019 | -2.7 | (-3.3,-2.1) | <0.001 | |||
男性 | 1990—1997 | -0.6 | (-0.9,-0.3) | <0.001 | -1.3 | (-1.4,-1.1) | <0.001 |
男性 | 1997—2004 | 1.7 | (1.3,2.1) | <0.001 | |||
男性 | 2004—2015 | -3.8 | (-3.9,-3.6) | <0.001 | |||
男性 | 2015—2019 | -0.6 | (-1.2,-0.1) | 0.026 |
年龄(岁) | AAPC(%) | 95%CI(%) | P值 |
---|---|---|---|
30~34 | -1.7 | (-2.6,-0.8) | <0.001 |
>34~39 | -2.2 | (-2.6,-1.8) | <0.001 |
>39~44 | -3.0 | (-3.3,-2.8) | <0.001 |
>44~49 | -2.7 | (-3.2,-2.2) | <0.001 |
>49~54 | -2.4 | (-2.7,-2.1) | <0.001 |
>54~59 | -2.3 | (-2.7,-1.9) | <0.001 |
>59~64 | -1.8 | (-2,-1.6) | <0.001 |
>64~69 | -1.8 | (-2.1,-1.4) | <0.001 |
>69~74 | -1.3 | (-1.6,-1.1) | <0.001 |
>74~79 | -1.0 | (-1.4,-0.6) | <0.001 |
>79~84 | -0.5 | (-0.8,-0.1) | 0.007 |
>84~89 | 0.2 | (0,0.5) | 0.042 |
>89~94 | -0.6 | (-0.9,-0.2) | 0.001 |
≥95 | -1.7 | (-2,-1.3) | <0.001 |
Table 2 Trends in age-specific mortality rates for esophageal cancer attributable to tobacco in China from 1990 to 2019
年龄(岁) | AAPC(%) | 95%CI(%) | P值 |
---|---|---|---|
30~34 | -1.7 | (-2.6,-0.8) | <0.001 |
>34~39 | -2.2 | (-2.6,-1.8) | <0.001 |
>39~44 | -3.0 | (-3.3,-2.8) | <0.001 |
>44~49 | -2.7 | (-3.2,-2.2) | <0.001 |
>49~54 | -2.4 | (-2.7,-2.1) | <0.001 |
>54~59 | -2.3 | (-2.7,-1.9) | <0.001 |
>59~64 | -1.8 | (-2,-1.6) | <0.001 |
>64~69 | -1.8 | (-2.1,-1.4) | <0.001 |
>69~74 | -1.3 | (-1.6,-1.1) | <0.001 |
>74~79 | -1.0 | (-1.4,-0.6) | <0.001 |
>79~84 | -0.5 | (-0.8,-0.1) | 0.007 |
>84~89 | 0.2 | (0,0.5) | 0.042 |
>89~94 | -0.6 | (-0.9,-0.2) | 0.001 |
≥95 | -1.7 | (-2,-1.3) | <0.001 |
[1] |
|
[2] |
|
[3] |
Global Burden of Disease Cancer Collaboration,
|
[4] |
GBD 2017 Oesophageal Cancer Collaborators. The global,regional,and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Gastroenterol Hepatol,2020,5(6):582-597. DOI:10.1016/S2468-1253(20)30007-8.
|
[5] |
GBD Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and teRRitories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1223-1249. DOI:10.1016/S0140-6736(20)30752-2.
|
[6] |
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1204-1222. DOI:10.1016/S0140-6736(20)30925-9.
|
[7] |
|
[8] |
曾四清. Joinpoint回归模型及其在传染病流行趋势分析中的应用[J]. 中国卫生统计,2019,36(5):787-791.
|
[9] |
曾四清,李艳,刘珺,等. 两组序列数据趋势变化特征对比分析的Joinpoint回归模型方法及应用[J]. 中国卫生统计,2021,38(2):307-311. DOI:10.3969/j.issn.1002-3674.2021.02.039.
|
[10] |
李辉章,杜灵彬. Joinpoint回归模型在肿瘤流行病学时间趋势分析中的应用[J]. 中华预防医学杂志,2020,54(8):908-912. DOI:10.3760/cma.j.cn112150-20200616-00889.
|
[11] |
|
[12] |
|
[13] |
梁珊珊,周智华,李成程,等. 1990—2019年中国糖尿病疾病负担及发病预测分析[J]. 中国全科医学,2023,26(16):2013-2019. DOI:10.12114/j.issn.1007-9572.2023.0009.
|
[14] |
许晴晴,严永富,陈浩,等. 中国四大慢性病死亡率可持续发展目标实现的预测研究[J]. 中华流行病学杂志,2022,43(6):878-884. DOI:10.3760/cma.j.cn112338-20211028-00830.
|
[15] |
陈飞,王悠清. 1990—2019年中国食管癌疾病负担及其变化趋势分析[J]. 中国肿瘤,2021,30(6):401-407. DOI:10.11735/j.issn.1004-0242.2021.06.A001.
|
[16] | |
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
健康中国行动(2019—2030年)[EB/OL].(2019-07-15)[2023-03-02].
|
[1] | ZHU Lu, AI Jun, LIAO Shengwu, HUANG Shuting, GONG Nirong, KONG Yaozhong, LIU Dehui, DOU Xianrui, ZHANG Guangqing. Association of Prognostic Nutritional Index with Cardiovascular Mortality in Patients with Peritoneal Dialysis: a Multicenter Retrospective Cohort Study [J]. Chinese General Practice, 2025, 28(05): 568-574. |
[2] | LAI Fengxia, WANG Shihong, ZHAO Le, HUANG Ruixian, YANG Zihua, ZHANG Zhiyi, KONG Danli, DING Yuanlin. Analysis and Prediction of Incidence and Mortality Trends of Three Enteric Infectious Diseases in China from 1990 to 2019 [J]. Chinese General Practice, 2025, 28(03): 313-319. |
[3] | LIU Mingbo, HE Xinye, YANG Xiaohong, WANG Zengwu. Interpretation of Report on Cardiovascular Health and Diseases in China 2023 [J]. Chinese General Practice, 2025, 28(01): 20-38. |
[4] | HONG Qiumian, LIAO Yanhui, JING Xiaojuan, ZHANG Ning. The Usage of Smoking Cessation Related Behavior Change Techniques by Medical Staff in Smoking Cessation Clinics in China and Its Relationship with the Success Rate of Smoking Cessation [J]. Chinese General Practice, 2024, 27(34): 4256-4263. |
[5] | ZHANG Xinyue, ZHANG Liangwen, FANG Ya. A Long-term Study on the Long-term Impact of Demographic Factors on the Burden of Ischemic Heart Disease in China from 1990 to 2019 [J]. Chinese General Practice, 2024, 27(27): 3388-3394. |
[6] | MIAO Lipeng, REN Kehao, LI Mengdie, LYU Juncheng. Trend Analysis and Prediction of Cardiovascular Disease Mortality in China from 2009 to 2021 [J]. Chinese General Practice, 2024, 27(18): 2260-2264. |
[7] | MA Xuefeng, HUANG Jun, LI Na, SHAO Huijuan, LU Lixia, YU Xiaohui, ZHANG Jiucong. Analysis of Disease Burden and Annual Change Trends of Gastroesophageal Reflux Disease in China from 1990 to 2019 [J]. Chinese General Practice, 2024, 27(18): 2265-2271. |
[8] | YIN Qiuguo, QIN Xintong, ZHANG Yidan, JIANG Peng, GUO Ping, JIA Xingtai, JIAN Liguo. Correlation between Insulin Resistance Metabolic Score and Poor Prognosis in Patients with Chronic Heart Failure [J]. Chinese General Practice, 2024, 27(18): 2179-2185. |
[9] | LIU Shanshan, LI Chuyi, ZHENG Ying, LU Lixia, LI Bin, YU Xiaohui, DANG Zheng. Disease Burden of Gallbladder Cancer in China from 1990 to 2019 and the Analysis of Its Future Trends [J]. Chinese General Practice, 2024, 27(14): 1742-1749. |
[10] | QU Yuanyuan, CAO Miao, WANG Jing, CHENG Li, HE Xiaoshuang. Trends in Prevalence and Burden of Asthma and Its Risk Factors in China, 1990-2019 [J]. Chinese General Practice, 2024, 27(13): 1594-1600. |
[11] | CHEN Dian, LONG Huanyu, LI Shurun, CHEN Yahong. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2024 Report [J]. Chinese General Practice, 2024, 27(13): 1533-1543. |
[12] | WU Xia, LIU Lan, ZHAO Yi, LI Guohui, CUI Wenlong, SUN Chenghuan, CAI Le. Changes in the Burden of Five Common Chronic Diseases among Rural Residents in Yunnan Province in 2011 and 2021 [J]. Chinese General Practice, 2024, 27(13): 1601-1607. |
[13] | ZHANG Shengnan, XU Shihua, HUANG Rongchao, CHEN Jian, ZHAO Chunru, MENG Minglyu, MA Yingjiao. Trend and Forecast Analysis of Premature Mortality Probability by Four Major Non-communicable Diseases in Baise from 2015 to 2021 [J]. Chinese General Practice, 2024, 27(11): 1387-1394. |
[14] | LIANG Dong, YANG Chenglin, LIN Xiaoru, ZHAO Yang, OUYANG Jiang, LIN Xiuquan. Burden of Cardiovascular Diseases Attributable to Diabetes among Chinese Adults from 1990 to 2019 [J]. Chinese General Practice, 2024, 27(11): 1380-1386. |
[15] | LI Yingchen, ZHAO Mingfang, WU Ying. Current Status of Lung Cancer Screening and Interpretation of the U.S. Preventive Services Task Force Guidelines on Lung Cancer Screening [J]. Chinese General Practice, 2024, 27(11): 1283-1287. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||